BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

343 related articles for article (PubMed ID: 30527358)

  • 21. lncRNA FLVCR1-AS1 silencing inhibits lung cancer cell proliferation, migration, and invasion by inhibiting the activity of the Wnt/β-catenin signaling pathway.
    Lin H; Shangguan Z; Zhu M; Bao L; Zhang Q; Pan S
    J Cell Biochem; 2019 Jun; 120(6):10625-10632. PubMed ID: 30697812
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long non-coding RNA SNHG20 promotes bladder cancer via activating the Wnt/β-catenin signalling pathway.
    Zhao Q; Gao S; Du Q; Liu Y
    Int J Mol Med; 2018 Nov; 42(5):2839-2848. PubMed ID: 30106094
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long noncoding RNA SNHG7 promotes the progression and growth of glioblastoma via inhibition of miR-5095.
    Ren J; Yang Y; Xue J; Xi Z; Hu L; Pan SJ; Sun Q
    Biochem Biophys Res Commun; 2018 Feb; 496(2):712-718. PubMed ID: 29360452
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Higher Expression of Linc00152 Promotes Bladder Cancer Proliferation and Metastasis by Activating the Wnt/β-Catenin Signaling Pathway.
    Xian-Li T; Hong L; Hong Z; Yuan L; Jun-Yong D; Peng X; Yan-Ping S; Fang Y; Nan L
    Med Sci Monit; 2019 May; 25():3221-3230. PubMed ID: 31042695
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long noncoding RNA papillary thyroid carcinoma susceptibility candidate 3 (PTCSC3) inhibits proliferation and invasion of glioma cells by suppressing the Wnt/β-catenin signaling pathway.
    Xia S; Ji R; Zhan W
    BMC Neurol; 2017 Feb; 17(1):30. PubMed ID: 28187755
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long non-coding RNA LINC01287 promotes breast cancer cells proliferation and metastasis by activating Wnt/ß-catenin signaling.
    Song C; Sun P; He Q; Liu LL; Cui J; Sun LM
    Eur Rev Med Pharmacol Sci; 2019 May; 23(10):4234-4242. PubMed ID: 31173295
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The long noncoding RNA ZFAS1 facilitates bladder cancer tumorigenesis by sponging miR-329.
    Wang JS; Liu QH; Cheng XH; Zhang WY; Jin YC
    Biomed Pharmacother; 2018 Jul; 103():174-181. PubMed ID: 29653362
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Down-regulation of lncRNA CASC2 promotes cell proliferation and metastasis of bladder cancer by activation of the Wnt/β-catenin signaling pathway.
    Pei Z; Du X; Song Y; Fan L; Li F; Gao Y; Wu R; Chen Y; Li W; Zhou H; Yang Y; Zeng J
    Oncotarget; 2017 Mar; 8(11):18145-18153. PubMed ID: 28199978
    [TBL] [Abstract][Full Text] [Related]  

  • 29. FOXM1-induced upregulation of lncRNA OR3A4 promotes the progression of diffuse large B-cell lymphoma via Wnt/β-catenin signaling pathway.
    Meng H; Zhao B; Wang Y
    Exp Mol Pathol; 2020 Aug; 115():104451. PubMed ID: 32417392
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Up-regulation of long non-coding RNA SNHG20 promotes ovarian cancer progression via Wnt/β-catenin signaling.
    He S; Zhao Y; Wang X; Deng Y; Wan Z; Yao S; Shen H
    Biosci Rep; 2018 Feb; 38(1):. PubMed ID: 29101241
    [TBL] [Abstract][Full Text] [Related]  

  • 31. LncRNA SNHG7 contributes to tumorigenesis and progression in breast cancer by interacting with miR-34a through EMT initiation and the Notch-1 pathway.
    Sun X; Huang T; Liu Z; Sun M; Luo S
    Eur J Pharmacol; 2019 Aug; 856():172407. PubMed ID: 31132353
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High-glucose promotes proliferation of human bladder cancer T24 cells by activating Wnt/β-catenin signaling pathway.
    Gao L; Xu FM; Shi WJ; Zhang S; Lu YL; Zhao DK; Long YF; Teng RB; Ge B
    Eur Rev Med Pharmacol Sci; 2018 Dec; 22(23):8151-8160. PubMed ID: 30556853
    [TBL] [Abstract][Full Text] [Related]  

  • 33. FOXO1-regulated lncRNA LINC01197 inhibits pancreatic adenocarcinoma cell proliferation by restraining Wnt/β-catenin signaling.
    Ling J; Wang F; Liu C; Dong X; Xue Y; Jia X; Song W; Li Q
    J Exp Clin Cancer Res; 2019 Apr; 38(1):179. PubMed ID: 31027497
    [TBL] [Abstract][Full Text] [Related]  

  • 34. LncRNA HOXD-AS1 promotes epithelial ovarian cancer cells proliferation and invasion by targeting miR-133a-3p and activating Wnt/β-catenin signaling pathway.
    Zhang Y; Dun Y; Zhou S; Huang XH
    Biomed Pharmacother; 2017 Dec; 96():1216-1221. PubMed ID: 29239819
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long non-coding RNA CASC9 promotes tumor growth and metastasis via modulating FZD6/Wnt/β-catenin signaling pathway in bladder cancer.
    Zhan Y; Zhang L; Yu S; Wen J; Liu Y; Zhang X
    J Exp Clin Cancer Res; 2020 Jul; 39(1):136. PubMed ID: 32677984
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long noncoding RNA PCAT6 regulates cell growth and metastasis via Wnt/β-catenin pathway and is a prognosis marker in cervical cancer.
    Lv XJ; Tang Q; Tu YQ; Yan DD; Wei QC
    Eur Rev Med Pharmacol Sci; 2019 Mar; 23(5):1947-1956. PubMed ID: 30915737
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long non-coding RNA LINC01225 promotes proliferation, invasion and migration of gastric cancer via Wnt/β-catenin signalling pathway.
    Xu Y; Zhang G; Zou C; Qi W; Gong Z; Zhang G; Ma G; Zhang W; Jiang P
    J Cell Mol Med; 2019 Nov; 23(11):7581-7591. PubMed ID: 31460694
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Downregulation of homeodomain-interacting protein kinase-2 contributes to bladder cancer metastasis by regulating Wnt signaling.
    Tan M; Gong H; Zeng Y; Tao L; Wang J; Jiang J; Xu D; Bao E; Qiu J; Liu Z
    J Cell Biochem; 2014 Oct; 115(10):1762-7. PubMed ID: 24824041
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The roles of Wnt/β-catenin signaling pathway related lncRNAs in cancer.
    Hu XY; Hou PF; Li TT; Quan HY; Li ML; Lin T; Liu JJ; Bai J; Zheng JN
    Int J Biol Sci; 2018; 14(14):2003-2011. PubMed ID: 30585264
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Reciprocal control of lncRNA-BCAT1 and β-catenin pathway reveals lncRNA-BCAT1 long non-coding RNA acts as a tumor suppressor in colorectal cancer.
    Xie F; Xiang X; Huang Q; Ran P; Yuan Y; Li Q; Qi G; Guo X; Xiao C; Zheng S
    Oncotarget; 2017 Apr; 8(14):23628-23637. PubMed ID: 28416735
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.